Osteogenic Differentiation of Mesenchymal Stromal Cells: A Comparative Analysis Between Human Subcutaneous Adipose Tissue and Dental Pulp
- 1 June 2017
- journal article
- research article
- Published by SAGE Publications in Stem Cells and Development
- Vol. 26 (11) , 843-855
Abstract
White adipose tissue is a source of mesenchymal stromal/stem cells (MSCs) that are actively studied for their possible therapeutic use in bone tissue repair/remodeling. To better appreciate the osteogenic potential of these cells, we compared some properties of MSCs from human subcutaneous adipose tissue [subcutaneous-adipose stromal cells (S-ASCs)] and dental pulp stem cell (DPSCs) of third-impacted molars, the latter representing a well-established MSC source. Both undifferentiated cell types showed similar fibroblast-like morphology and mesenchymal marker expression. However, undifferentiated S-ASCs displayed a faster doubling time coupled to greater proliferation and colony-forming ability than DPSCs. Also, the osteogenic differentiation of S-ASCs was greater than that of DPSCs, as evaluated by the higher levels of expression of early osteogenic markers Runt-related transcription factor-2 (RUNX2) and alkaline phosphatase at days 3–14 and of extracellular matrix mineralization at days 14–21. Moreover, S-ASCs showed a better colonization of the titanium scaffold. In addition, we investigated whether S-ASC osteogenic commitment was enhanced by adenosine A1 receptor (A1R) stimulation, as previously shown for DPSCs. Although A1R expression was constant during DPSC differentiation, it increased in S-ASC at day 21 from osteogenesis induction. Accordingly, A1R stimulation by the agonist 2-chloro-N6-cyclopentyl-adenosine, added to the cultures at each medium change, stimulated proliferation only in differentiating DPSC and enhanced the osteogenic differentiation earlier in DPSCs than in S-ASCs. These effects were counteracted by cell pretreatment with a selective A1R antagonist. Thus, our findings suggest that S-ASCs could be advantageously used in regenerative orthopedics/dentistry, and locally released or exogenously added purines may play a role in bone repair/remodeling, even though this aspect should be more thoroughly evaluated.Keywords
This publication has 54 references indexed in Scilit:
- Molecular and Phenotypic Characterization of Human Amniotic Fluid-Derived Cells: A Morphological and Proteomic ApproachStem Cells and Development, 2015
- Are Mesenchymal Cells Indeed Pluripotent Stem Cells or Just Stromal Cells? OCT-4 and VSELs Biology Has Led to Better UnderstandingStem Cells International, 2013
- Wnt Signaling Behaves as a “Master Regulator” in the Osteogenic and Adipogenic Commitment of Human Amniotic Fluid Mesenchymal Stem CellsStem Cell Reviews and Reports, 2013
- Human Amniotic Fluid Stem Cells as an Attractive Tool for Clinical ApplicationsCurrent Stem Cell Research & Therapy, 2013
- The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicineNature Medicine, 2013
- Potential antitumor therapeutic strategies of human amniotic membrane and amniotic fluid-derived stem cellsCancer Gene Therapy, 2012
- Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches2010
- Defining the risks of mesenchymal stromal cell therapyCytotherapy, 2010
- Europe Confronts the Embryonic Stem Cell Research ChallengeScience, 2000
- STROMAL CELLS RESPONSIBLE FOR TRANSFERRING THE MICROENVIRONMENT OF THE HEMOPOIETIC TISSUESTransplantation, 1974